Editorial: Mechanisms in hypertension.
D000804:Angiotensin II / Q000031:analogs & derivatives*; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D009842:Oligopeptides / Q000494:pharmacology*; D051381:Rats; D012083:Renin / Q000378:metabolism; D012504:Saralasin / Q000627:therapeutic use; D013722:Teprotide / Q000494:pharmacology* / Q000627:therapeutic use; D000092502:Renin Inhibitors
D000804:Angiotensin II; D000959:Antihypertensive Agents; D009842:Oligopeptides; D012083:Renin; D012504:Saralasin; D013722:Teprotide; D000092502:Renin Inhibitors